Clinical Trial Update: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study of Durvalumab plus Tremelimumab with platinum-based chemotherapy for intrahepatic cholangiocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• IMFINZI (DURVALUMAB)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cholangiocarcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-11-05